(recombinant human) GM-CSF
Showing 1 - 25 of >10,000
Melanoma Trial in Beijing (OH2 injection, HX008 injection)
Recruiting
- Melanoma
- OH2 injection
- HX008 injection
-
Beijing, Beijing, ChinaPeking University Cancer Hospital
Jan 28, 2023
Solid Tumor, Melanoma Trial in Beijing (OH2 injection, Keytruda)
Recruiting
- Solid Tumor
- Melanoma
- OH2 injection
- Keytruda
-
Beijing, Beijing, ChinaPeking University Cancer Hospital
Apr 1, 2022
Neuroblastoma Trial in Guangzhou (Naxitamab monotherapy, GM-CSF, Irinotecan)
Recruiting
- Neuroblastoma
- Naxitamab monotherapy
- +6 more
-
Guangzhou, Guangdong, ChinaSun Yat-sen University Cancer Center
Aug 31, 2023
Advanced Solid Tumor, Refractory Tumor Trial in Suzhou (Radiotherapy, PD-1/PD-L1 inhibitor, Granulocyte-macrophage
Recruiting
- Advanced Solid Tumor
- Refractory Tumor
- Radiotherapy
- +4 more
-
Suzhou, ChinaThe Second Affiliated Hospital of SchoowUniversity
Sep 14, 2023
Advanced Solid Tumor, Refractory Tumor Trial in Suzhou (Thymalfasin, Radiotherapy, PD-1/PD-L1 inhibitor)
Recruiting
- Advanced Solid Tumor
- Refractory Tumor
- Thymalfasin
- +3 more
-
Suzhou, ChinaThe Second Affiliated Hospital of SchoowUniversity
Mar 29, 2023
Local Progression or Metastatic Melanoma With Failed First-line Treatment Trial in Beijing (Pexa-Vec combined with ZKAB001,
Recruiting
- Local Progression or Metastatic Melanoma With Failed First-line Treatment
- Pexa-Vec combined with ZKAB001
- ZKAB001 monotherapy
-
Beijing, ChinaBeijing Cancer Hospital
Mar 30, 2022
Autoimmune Pulmonary Alveolar Proteinosis Trial in Los Altos, Cincinnati (Sargramostim)
Completed
- Autoimmune Pulmonary Alveolar Proteinosis
-
Los Altos, California
- +1 more
Aug 2, 2021
Metastatic Pancreatic Adenocarcinoma, Recurrent Pancreatic Carcinoma, Stage III Pancreatic Cancer Trial in Detroit (biological,
Completed
- Metastatic Pancreatic Adenocarcinoma
- +3 more
- Aldesleukin
- +9 more
-
Detroit, MichiganWayne State University/Karmanos Cancer Institute
Mar 30, 2022
Prostate Cancer Trial in New Brunswick, Seattle, Madison (pTVG-AR, gm-csf)
Completed
- Prostate Cancer
- pTVG-AR
- gm-csf
-
New Brunswick, New Jersey
- +2 more
Feb 2, 2021
Sarcoma, Kaposi, HIV Trial in New York (Interferon alfa-2b, Zidovudine, Sargramostim)
Completed
- Sarcoma, Kaposi
- HIV Infections
- Interferon alfa-2b
- +2 more
-
New York, New YorkMem Sloan - Kettering Cancer Ctr
Oct 26, 2021
Autoimmune Pulmonary Alveolar Proteinosis Trial in Worldwide (Molgramostim)
Completed
- Autoimmune Pulmonary Alveolar Proteinosis
-
Århus, Denmark
- +12 more
Feb 2, 2021
Lymphoma Trial in Changchun (PEG-rhG-CSF, RhG-CSF)
Not yet recruiting
- Lymphoma
-
Changchun, Jilin, ChinaThe First Bethune Hospital of Jilin University
Apr 18, 2023
Granulocyte Colony-stimulating Factor, Stem Cell Mobilization Trial (PEG-rhG-CSF)
Not yet recruiting
- Granulocyte Colony-stimulating Factor
- Stem Cell Mobilization
- (no location specified)
Jun 13, 2022
Colorectal Tumors Trial in Xiamen (hypofractionation Radiotherapy, sintilimab, GM-CSF)
Recruiting
- Colorectal Neoplasms
- hypofractionation Radiotherapy
- +3 more
-
Xiamen, Fujian, ChinaThe First Affiliated Hospital of Xiamen University
Mar 28, 2022
Lymphoma, Multiple Myeloma Trial in Chongqing (pegylated recombinant human granulocyte-colony stimulating factor)
Recruiting
- Lymphoma
- Multiple Myeloma
- pegylated recombinant human granulocyte-colony stimulating factor
-
Chongqing, Chongqing, ChinaChongqing University Cancer Hospital
Sep 23, 2023
Glioblastoma Trial in Durham (Human CMV pp65-LAMP mRNA-pulsed autologous DCs containing GM CSF, Temozolomide, Tetanus-Diphtheria
Suspended
- Glioblastoma
- Human CMV pp65-LAMP mRNA-pulsed autologous DCs containing GM CSF
- +4 more
-
Durham, North CarolinaDuke University Medical Center
Aug 16, 2022
Down Syndrome Trial in Aurora (Sargramostim for Injection, Saline Placebo)
Not yet recruiting
- Down Syndrome
- Sargramostim for Injection
- Saline Placebo
-
Aurora, ColoradoUniversity of Colorado Anschutz Medical Campus
Jul 28, 2022
Sarcoma, Kaposi, HIV Trial in United States (Bleomycin sulfate, Vincristine sulfate, Doxorubicin HCl)
Completed
- Sarcoma, Kaposi
- HIV Infections
- Bleomycin sulfate
- +4 more
-
Los Angeles, California
- +4 more
Oct 26, 2021
HIV Trial in United States (APL 400-047, ALVAC-HIV MN120TMG (vCP205), Sargramostim)
Completed
- HIV Infections
- APL 400-047
- +2 more
-
Birmingham, Alabama
- +3 more
Oct 28, 2021
Cirrhosis Trial in New Delhi (GMCSF, Placebo)
Unknown status
- Cirrhosis
- GMCSF
- Placebo
-
New Delhi, Delhi, IndiaInstitute of Liver and Biliary Sciences
Feb 18, 2020
IVF, PCOS, IVM Trial in Ho Chi Minh City (GM-CSF group, Control group)
Recruiting
- IVF
- +2 more
- GM-CSF group
- Control group
-
Ho Chi Minh City, VietnamMy Duc Hospital
Jul 12, 2021
Melanoma Trial in Beijing (OrienX010 combination with JS001)
Recruiting
- Melanoma
- OrienX010 combination with JS001
-
Beijing, Beijing, ChinaBeijing Cancer Hospital
Dec 18, 2019
Melanoma (Skin) Trial in Beijing (OrienX010 injection, Dacarbazine (DTIC))
Recruiting
- Melanoma (Skin)
- OrienX010 injection
- Dacarbazine (DTIC)
-
Beijing, Beijing, ChinaBeijing Cancer Hospital
Feb 25, 2020
Anatomic Stage IV Breast Cancer AJCC v8, Metastatic Breast Carcinoma, Prognostic Stage IV Breast Cancer AJCC v8 Trial in
Withdrawn
- Anatomic Stage IV Breast Cancer AJCC v8
- +4 more
- Cyclophosphamide
- +5 more
-
Philadelphia, PennsylvaniaSidney Kimmel Cancer Center at Thomas Jefferson University
Jun 3, 2021